Philip Crosbie

11.4k total citations · 1 hit paper
86 papers, 2.1k citations indexed

About

Philip Crosbie is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philip Crosbie has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philip Crosbie's work include Lung Cancer Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (31 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). Philip Crosbie is often cited by papers focused on Lung Cancer Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (31 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). Philip Crosbie collaborates with scholars based in United Kingdom, United States and France. Philip Crosbie's co-authors include Haval Balata, Caroline Dive, Anthony D. Whetton, Maria Pernemalm, Steven L. Wood, Sean Knight, Tracy Hussell, Jakub Chudziak, Richard Booton and Mark Woodhead and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Philip Crosbie

72 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Progress and prospects of early detection in lung cancer

2017 673 citations Sean Knight, Philip Crosbie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Crosbie United Kingdom	21	1.1k	778	590	566	268	86	2.1k
Jiahua Pan China	27	895 0.8×	671 0.9×	490 0.8×	482 0.9×	162 0.6×	112	2.0k
Regina Kwon United States	5	1.1k 1.0×	1.4k 1.8×	859 1.5×	908 1.6×	146 0.5×	10	2.5k
Zhengbo Song China	28	1.4k 1.3×	790 1.0×	1.2k 2.0×	508 0.9×	145 0.5×	162	2.5k
Stijn L.W. Koolen Netherlands	25	755 0.7×	545 0.7×	1.1k 1.8×	253 0.4×	188 0.7×	155	2.3k
Bin Xu China	22	465 0.4×	728 0.9×	613 1.0×	489 0.9×	129 0.5×	97	1.9k
J. Alex United States	18	750 0.7×	1.0k 1.3×	456 0.8×	885 1.6×	124 0.5×	42	2.4k
Takeshi Isobe Japan	23	884 0.8×	696 0.9×	897 1.5×	286 0.5×	131 0.5×	130	2.2k
Xiangning Fu China	27	775 0.7×	828 1.1×	593 1.0×	569 1.0×	127 0.5×	132	2.3k
Benjamin Levy United States	23	1.1k 1.1×	526 0.7×	966 1.6×	503 0.9×	197 0.7×	97	1.9k
Pin Zhang China	24	585 0.6×	508 0.7×	1.3k 2.2×	791 1.4×	250 0.9×	153	2.3k

Countries citing papers authored by Philip Crosbie

Since Specialization

Citations

This map shows the geographic impact of Philip Crosbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Crosbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Crosbie more than expected).

Fields of papers citing papers by Philip Crosbie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Crosbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Crosbie. The network helps show where Philip Crosbie may publish in the future.

Co-authorship network of co-authors of Philip Crosbie

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Crosbie. A scholar is included among the top collaborators of Philip Crosbie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Crosbie. Philip Crosbie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balata, Haval, et al.. (2024). Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort. SHILAP Revista de lepidopterología. 3(1). e000560–e000560. 1 indexed citations

Hancock, Neil, Suzanne Rogerson, Rhian Gabe, et al.. (2024). Yorkshire Lung Screening Trial (YLST) pathway navigation study: a protocol for a nested randomised controlled trial to evaluate the effect of a pathway navigation intervention on lung cancer screening uptake. BMJ Open. 14(7). e084577–e084577.

Crosbie, Philip, et al.. (2023). Pilot study of lung cancer screening for survivors of Hodgkin lymphoma. Haematologica. 109(10). 3305–3313. 1 indexed citations

Beirne, Paul, Bobby Bhartia, Philip Crosbie, et al.. (2023). Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial. BMJ Open Respiratory Research. 10(1). e001490–e001490. 5 indexed citations

Baldwin, David, Richard Booton, Mike Darby, et al.. (2023). Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD. ERJ Open Research. 9(4). 203–2023. 8 indexed citations

Smith, Miriam J., Emma J. Crosbie, John Bowes, et al.. (2023). Validation of lung cancer polygenic risk scores in a high-risk case-control cohort. Genetics in Medicine. 25(8). 100882–100882. 4 indexed citations

Kumar, Neelam Sanjeev, et al.. (2023). Abstract 3319: Breath-based detection of lung cancer using exogenous volatile organic compound targeting β-glucuronidase in the tumor microenvironment. Cancer Research. 83(7_Supplement). 3319–3319. 1 indexed citations

Khan, Sam, Robert C. Rintoul, Coral Pepper, et al.. (2023). Lung cancer in never smokers (LCINS): development of a UK national research strategy. PubMed. 1(1). 21–21. 6 indexed citations

O’Dowd, Emma, Samuel WD Merriel, Vinton W.T. Cheng, et al.. (2023). Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review. BMC Cancer. 23(1). 820–820. 5 indexed citations

10.

Balata, Haval, et al.. (2022). Incidental findings in low dose CT lung cancer screening of high-risk smokers: Results from the Manchester lung Health Check pilot. Lung Cancer. 173. 1–4. 6 indexed citations

11.

Quinn-Scoggins, Harriet, Rachael L Murray, Samantha L. Quaife, et al.. (2022). Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context. BMC Pulmonary Medicine. 22(1). 478–478. 5 indexed citations

12.

Robbins, Hilary A., Karine Alcala, Anthony J. Swerdlow, et al.. (2021). Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom. British Journal of Cancer. 124(12). 2026–2034. 33 indexed citations

13.

Balata, Haval, Mamta Ruparel, Emma O’Dowd, et al.. (2021). Analysis of the baseline performance of five UK lung cancer screening programmes. Lung Cancer. 161. 136–140. 33 indexed citations

14.

Balata, Haval, Sean Knight, Christopher J. Armitage, et al.. (2019). Attending community-based lung cancer screening influences smoking behaviour in deprived populations. Lung Cancer. 139. 41–46. 15 indexed citations

15.

Evison, Matthew, Philip Crosbie, Raffaele Califano, et al.. (2015). Can EBUS-TBNA Provide an Accurate Diagnosis in Patients Found to Have Enlarged or FDG-avid Lymph Nodes During Surveillance of Previously Treated Lung Cancer?. Journal of Bronchology & Interventional Pulmonology. 22(2). 114–120. 5 indexed citations

16.

Evison, Matthew, et al.. (2014). Can computed tomography characteristics predict outcomes in patients undergoing radial EBUS-guided biopsy of peripheral lung lesions?. European Respiratory Journal. 44(Suppl 58). P678–P678. 1 indexed citations

17.

Wood, Steven L., Maria Pernemalm, Philip Crosbie, & Anthony D. Whetton. (2013). The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treatment Reviews. 40(4). 558–566. 367 indexed citations

18.

Crosbie, Philip, Amanda J. Watson, Raymond Agius, et al.. (2012). Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 732(1-2). 43–46. 24 indexed citations

19.

Crosbie, Philip, et al.. (2005). A rare complication of pneumonectomy: Diagnosis made by a literature search. Respiratory Medicine. 99(9). 1198–1200. 2 indexed citations

20.

Crosbie, Philip, et al.. (2004). N7-methyldeoxyguanosine and oxidative DNA adducts associations with lung carcinoma and smoking. Thorax. 59(1). 23–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact